DrugInformations.org

Schering-Plough Corporation (NYSE: SGP) announced that an overview of asenapine clinical trials from the Olympia program was presented at the 161st Annual Meeting of the American Psychiatric Association in Washington, D.C., May 3-8. Data from the studies, involving patients with bipolar I disorder and schizophrenia, were presented in two oral presentations (Abstracts # 44 and # 80).

More: continued here

No Comments »

Despite intriguing findings that omega 3 fatty acid supplements could alleviate depression symptoms, there is still not enough evidence to say whether omega 3s are useful treatments for people with bipolar disorder, according to a review of recent studies.

More: continued here

No Comments »

A new study by Rhode Island Hospital and Brown University researchers reports that fewer than half the patients previously diagnosed with bipolar disorder received a diagnosis of bipolar disorder based on a comprehensive, psychiatric diagnostic interview –the Structured Clinical Interview for DSM-IV (SCID).

More: continued here

No Comments »

Most people believe that the way we see things is affected by how we feel emotionally. Does our mood really change what we see or do individuals with certain genetic traits always tend to see things differently, regardless of their mood? Earlier research suggested that people with bipolar mood disorder might alternate their perception more slowly when looking at ambiguous figures.

More: continued here

No Comments »

On April 8, 2008, the European Commission made a decision to allow thedrug ABILIFY® (aripiprazole) to be marketed. ABILIFY treats moderate tosevere manic episodes for patients with Bipolar I Disorder and it isdesigned to prevent new manic episodes in patients who experiencepredominately manic episodes.Before this decision, the European Committee for Medicinal Products forHuman Use (CHMP) issued a positive opinion in mid-February 2008.

More: continued here

No Comments »

Alkermes, Inc. (NASDAQ: ALKS) announced that its partner, Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD), submitted a Supplemental New Drug Application (sNDA) for RISPERDAL® CONSTA® [(risperidone) Long-Acting Injection] to the U.S. Food and Drug Administration (FDA) seeking approval for adjunctive maintenance treatment to delay the occurrence of mood episodes in patients with frequently relapsing bipolar disorder (FRBD).

More: continued here

No Comments »

New pivotal trial data from two clinical studies with SEROQUEL XR? (quetiapine fumarate) once daily Extended Release Tablets were presented today at the Eighth International Review of Bipolar Disorder (IRBD) Conference in Copenhagen, Denmark.

More: continued here

No Comments »

Famous bipolar people include some of the world’s foremost musicians, actors, writers, composers and scientists. A new contest launched on YouTube uses the current interest in bipolar celebrities to raise awareness about bipolar disorder. The Famous Bipolar People Contest encourages research and reflection. According to contest organizers from www.bipolar-lives.

More: continued here

No Comments »

Bipolar Disorder (BPD or manic-depressive illness) is one of the most serious of all mental disorders, affecting millions of individuals worldwide. Affected individuals alternate between states of deep depression and mania. While depression is characterized by persistent and long-term sadness or despair, mania is a mental state characterized by great excitement, flight of ideas, a decreased need for sleep, and, sometimes, uncontrollable behavior, hallucinations, or delusions.

More: continued here

No Comments »

The drug tamoxifen is usually used to treat breast cancer, butresearchers say that it also may reduce symptoms of mania in peoplewith bipolar disorder. An article summarizing the small, three-weektrial of tamoxifen is published in Archives of GeneralPsychiatry.As a treatment for breast cancer, tamoxifen impacts the way in whichthe hormone estrogen works in the body. In addition, tamoxifen worksagainst the actions of the protein kinase C family of enzymes.

More: continued here

No Comments »